Drug manufacturers' 340B contract pharmacy restrictions have pulled $8.4 billion out of the savings hospitals achieve using contract pharmacies to dispense 340B drugs, a new 340B Health study found.

UPDATED: Contract Pharmacy Restrictions Cut $1.5 Billion in 340B Hospital Revenue, $8.4 Billion More Endangered, Report Says

July 13, 2023 Rich Daly, Editor in Chief Views

Early, limited versions of contract pharmacy restrictions for 340B hospitals cut their revenue by $1.5 billion in one year, according [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

UPDATED: Contract Pharmacy Restrictions Cut $1.5 Billion in 340B Hospital Revenue, $8.4 Billion More Endangered, Report Says

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Rich Daly

UPDATED: Contract Pharmacy Restrictions Cut $1.5 Billion in 340B Hospital Revenue, $8.4 Billion More Endangered, Report Says

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Rich Daly

Site Footer Live